Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05608629 · ClinicalTrials.gov registry record · NA
Vagus Nerve Stimulation as Treatment for Long Covid
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT05608629 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 17 participants.
The verdict
NCT05608629, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Many patients do not recover following Covid infection. The resulting illness is called Long Covid. Because there is no agreed upon treatment for this ailment, the research team has decided to do an open label pilot study using non-invasive, transcutaneous stimulation of the auricular branch of the vagus nerve. Inclusion criteria required the patient to fulfill criteria for having chronic fatigue syndrome. To date, fourteen patients provided evaluable data. Eight of these fulfilled the study's requirements for treatment success.
Interventions
- DEVICE Transcutaneous Non-Invasive Vagus Nerve Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-06-06 |
| Est. Completion | 2022-12-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05608629
The ClinicalTrials.gov registry entry for NCT05608629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcutaneous Non-Invasive Vagus Nerve Stimulation is the first listed.
NCT05608629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05608629 about?
NCT05608629 is a clinical study titled "Vagus Nerve Stimulation as Treatment for Long Covid". Many patients do not recover following Covid infection. The resulting illness is called Long Covid. Because there is no agreed upon treatment for this ailment, the research team has decided to do an open label pilot study using non-invasive, transcutaneous stimulation of the auricular branch of the ...
What is the current status of trial NCT05608629?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2022-06-06. Estimated completion is 2022-12-05.
What interventions are being tested in trial NCT05608629?
The interventions under investigation include: Transcutaneous Non-Invasive Vagus Nerve Stimulation (DEVICE).
Who is sponsoring clinical trial NCT05608629?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.